Ingersoll Rand Inc. (IR): BCG Matrix [June-2026 Updated]

This ready-made BCG Matrix Analysis of Ingersoll Rand Inc. Business gives you a practical, research-based view of where the portfolio is growing, where it is generating cash, and where capital should be focused next. It highlights PST as the clearest Star with $420M of Q1 2026 orders and a 30.3% EBITDA margin, IT&S as the main Cash Cow with $1.56B of Q1 orders and recurring revenue expected to exceed 40%, and newer moves like the $46.7M Scinomix deal and the May 4, 2026 Fox acquisition as Question Marks still building scale. You also learn how the company used $1.22B of 2025 free cash flow, $3.9B of liquidity, and 1.7x net debt to EBITDA to fund growth, returns, and M&A while navigating weaker organic orders and tariff risk.

Ingersoll Rand Inc. - BCG Matrix Analysis: Stars

Ingersoll Rand Inc.'s clearest Star is its PST segment because it combines strong order growth, the company's highest margin profile, and continued capital deployment. The digital and life sciences-related businesses also fit the Star category because they are growing faster than the core industrial base and are being backed by acquisition activity, recurring revenue, and expanding connected-device scale.

Star Segment Snapshot

PST premium growth engine

PST looks like the strongest Star because it pairs scale with margin leadership. In Q1 2026, the segment generated $420M of orders, which was up 6% reported and 1% organically. That is important because organic growth strips out acquisition effects and shows underlying demand. Its adjusted EBITDA margin was 30.3%, above the 26.7% margin for IT&S, making PST the highest-margin operating platform in the company. In BCG terms, that combination matters because a Star should have both strong market momentum and the ability to fund further expansion from internal earnings.

Management is reinforcing PST rather than just riding its current momentum. In June 2025, Michael Weatherred's role was expanded over PST, and Ingersoll Rand closed the Fox s.r.l. acquisition on May 4, 2026. That tells you the company sees PST as a long-term growth pool, not a mature cash cow. The segment also sits inside a company that guided 2026 adjusted EBITDA to $2.13B to $2.19B and adjusted EPS to $3.45 to $3.57, which gives it room to keep investing while still protecting returns.

Life sciences automation scale-up

The January 2026 acquisition of Scinomix for $46.7M expands automation workflow capability in Life Sciences. That matters because management has explicitly shifted strategic focus toward Life Sciences, Pharma, and Water, which are described as higher-margin and more resilient than more cyclical industrial end markets. In BCG terms, a business like this can behave like a Star when the addressable market is expanding and the company has a credible path to win share through product breadth and workflow automation.

The digital layer strengthens the Star case. The iConn platform had a connected unit base above 115,000 units globally in January 2026, which supports subscription-style and service-linked revenue. Recurring revenue is projected to exceed 40% of total revenue by end-2025, and that matters because recurring revenue is usually more stable than one-time equipment sales. Ingersoll Rand also delivered $7.65B of 2025 revenue and $1.22B of free cash flow, so this platform can be funded without putting pressure on liquidity.

Precision dosing upmarket shift

The completed Fox s.r.l. acquisition strengthens metering and dosing pump capability inside PST. That business fits the move toward Pharma and Water, where demand is typically more resilient than in cyclical project equipment. Even though PST's $420M of Q1 2026 orders was much smaller than IT&S's $1.56B, PST produced the stronger 30.3% EBITDA margin. This is exactly why it belongs in the Star quadrant: it is smaller in volume than some peers, but it converts growth into profit more efficiently.

The precision dosing story also has runway because the addressable market is being expanded through bolt-on M&A. That makes the segment more than a narrow product line; it becomes a broader platform for Pharma and Water customers. The company's June 11, 2026 Annual Meeting and continued leadership under Vicente Reynal suggest continuity behind this growth push, which matters because Stars need consistent execution to hold their position while the market expands.

• PST is the clearest Star because it combines 6% reported order growth, 30.3% EBITDA margin, and acquisition-led expansion.
• Life Sciences is a Star-style growth platform because of the $46.7M Scinomix deal and the strategic shift toward higher-margin end markets.
• iConn supports Star behavior through a connected base above 115,000 units and recurring revenue above 40% of total revenue.
• Cash generation matters because $1.22B of free cash flow and 1.7x net debt to adjusted EBITDA give room to keep investing.

Digital service monetization

The iConn platform is a Star-type growth engine because it turns installed equipment into ongoing revenue. The connected base rising above 115,000 units globally means Ingersoll Rand has a larger pool of assets that can generate monitoring, service, and software-linked revenue. That matters in BCG terms because Stars are not just about selling more units; they are about building a business that can keep growing after the first sale. Recurring revenue projected to exceed 40% of total revenue makes the revenue mix more durable and less exposed to short-cycle capital spending.

The company's financial position supports this strategy. Full-year 2025 free cash flow was $1.22B, with 105% conversion of net income, showing strong cash generation relative to reported profit. Q1 2026 revenue increased 8% to $1.85B, adjusted EBITDA was $469M, net debt to adjusted EBITDA stayed at 1.7x, and total liquidity was $3.9B with $1.3B of cash. That gives the company the balance-sheet flexibility to keep funding digital expansion without overstretching leverage.

Ingersoll Rand Inc. - BCG Matrix Analysis: Cash Cows

Ingersoll Rand Inc.'s Cash Cow position is strongest in its Industrial Technologies and Services segment, where a large installed base, recurring aftermarket demand, and steady cash conversion produce reliable earnings. The business is mature, profitable, and capable of funding shareholder returns without needing aggressive reinvestment.

The clearest sign of Cash Cow behavior is the mix of scale and recurring revenue. Management expects recurring revenue to exceed 40% of total revenue by the end of 2025, which matters because service, parts, and digital monitoring typically generate higher margin and repeat sales than original equipment. That makes the core platform a stable source of cash, even when organic growth slows.

The installed base engine is the heart of the Cash Cow profile. The Industrial Technologies and Services segment delivered $1.56B of Q1 2026 orders, up 5% reported despite a 3% organic decline. That gap matters because it shows the business can keep growing through acquisitions or mix even when underlying demand is flat. A 26.7% adjusted EBITDA margin also shows the segment is not just big, but highly profitable.

Full-year 2025 performance reinforces the same point. Revenue reached $7.65B, up 6%, while free cash flow was $1.22B. Free cash flow is the cash left after operating expenses and capital spending, and it is one of the best signs of a Cash Cow. A conversion rate of 105% of net income means the business turned accounting profit into slightly more cash than profit, which is a strong sign of working capital discipline.

The shareholder return machine also fits the Cash Cow label. In full-year 2025, Ingersoll Rand returned $1.05B to shareholders through buybacks and dividends. In Q1 2026, it repurchased $89M of stock and paid $8M in dividends, while the board declared a quarterly dividend of $0.02 per share. That pattern shows the company is generating enough excess cash to reward shareholders instead of needing to conserve every dollar for survival or expansion.

• Full-year 2025 shareholder returns: $1.05B
• Q1 2026 share repurchases: $89M
• Q1 2026 dividends paid: $8M
• Quarterly dividend declared: $0.02 per share
• Shares outstanding as of April 16, 2026: 391.33M
• Institutional ownership in June 2026: about 95.8%

The balance sheet supports the Cash Cow profile too. Net debt to adjusted EBITDA was only 1.7x, and total liquidity was $3.9B, including $1.3B of cash. Net debt to adjusted EBITDA measures how many years of current EBITDA it would take to repay net debt. A ratio below 2x usually signals a conservative capital structure, which gives management room to return cash and still absorb downturns.

The mature revenue base matters because Cash Cows are not defined by fast growth. They are defined by dependable earnings and cash generation. In Q1 2026, Ingersoll Rand posted $1.85B of revenue, up 8% year over year, and $192M of net income. Adjusted EBITDA reached $469M in the quarter. Full-year 2026 guidance calls for only 2.5% to 4.5% revenue growth, which is consistent with a mature business rather than a high-growth one.

Aftermarket service depth is the most dependable cash source in the portfolio. Recurring revenue should exceed 40% of total revenue by the end of 2025, supported by parts, service, and digital offerings. In a Cash Cow business, repeat sales matter because they usually carry lower selling cost, better customer retention, and steadier margins than new equipment sales.

The connected installed base adds another layer of stability. More than 115,000 iConn units strengthen repeat service demand by creating ongoing monitoring and maintenance needs. That installed base increases the chance of recurring transactions, which helps explain why the company can generate $163M of free cash flow in Q1 2026 even though that was below the $223M recorded in Q1 2025.

• Recurring revenue target: above 40% of total revenue by end-2025
• Connected installed base: more than 115,000 iConn units
• Q1 2026 free cash flow: $163M
• Q1 2025 free cash flow: $223M
• 2025 transactions completed: 16
• Capital deployed in 2025: $525M
• Annualized inorganic revenue supported: about $275M

The acquisition activity also strengthens the Cash Cow profile because it feeds the service engine. In 2025, the company completed 16 transactions and deployed $525M for about $275M of annualized inorganic revenue. That matters because acquired revenue can deepen the installed base, expand service exposure, and raise the share of recurring sales over time.

For BCG Matrix analysis, the Cash Cow label fits because the segment has high market position, modest growth, and strong cash generation. In academic work, you can use this case to show how mature industrial companies create value through aftermarket depth, disciplined capital allocation, and balance sheet strength rather than rapid expansion.

Ingersoll Rand Inc. - BCG Matrix Analysis: Question Marks

These assets fit the Question Mark bucket because they sit in attractive markets, but their market share, revenue contribution, and return profile are not yet proven. Ingersoll Rand is spending into growth areas, but the disclosed data still show build-out rather than dominance.

Scinomix platform buildout is a small but strategic move in life sciences automation. The January 2026 acquisition cost $46.7M, which is modest against Ingersoll Rand's $7.65B of 2025 revenue and $1.22B of free cash flow. That scale gap matters because it tells you the deal is not large enough to shift the company's financial profile on its own. Management has made Life Sciences a priority because it is a resilient end market, but the deal is still early in integration, so there is no clear evidence yet of share gains or margin lift. Ingersoll Rand completed 16 transactions in 2025 and deployed $525M, so Scinomix looks like one step in a broader acquisition engine rather than a standalone leader.

Fox dosing expansion also sits in Question Mark territory. The Fox s.r.l. acquisition was finalized on May 4, 2026 to strengthen metering and dosing pump capability inside PST. That market is attractive because PST already posted $420M of Q1 orders and a 30.3% EBITDA margin, which means the platform is healthy and profitable. But Fox is still a bolt-on acquisition, not a scaled market leader, and the latest data do not disclose Fox revenue contribution. Ingersoll Rand's $3.45 to $3.57 adjusted EPS guidance for 2026 shows financial capacity to invest, but not proof that Fox has already created a defensible competitive position.

RNG solution expansion is another Question Mark because the market opportunity is real, but the operating economics are still unsettled. The July 2025 purchase of TMIC and Adicomp for about €160M expanded renewable natural gas capabilities and tied the company more closely to energy transition demand. That is strategically important because decarbonization projects can create long-term equipment demand. The problem is that the latest disclosed data do not show segment revenue share, organic growth, or margin contribution from the RNG assets. Integration also happens in a tougher environment, since tariffs and supply chain risk can slow project timing, raise costs, and delay customer adoption.

Oil free compressor technology is a classic Question Mark because the technical opportunity is attractive, but commercialization is not yet visible in the numbers. The May 12, 2026 partnership with Garrett Motion targets next-generation oil-free industrial centrifugal compressor technologies, which could support efficiency-focused demand and cleaner industrial applications. That fits a market where customers want lower contamination risk and better performance. But the latest public data do not show orders, revenue, or margin contribution from the partnership. At the same time, Middle East tensions delayed about $40M of long-cycle project orders in Q1 2026, which shows how geopolitical volatility can slow conversion from technology promise into revenue.

India capacity expansion also belongs in the Question Mark category. The mid-2025 operationalization of new manufacturing hubs in India is aimed at regional demand for energy-efficient compressors, which gives the company exposure to a large industrial market with long runway. Yet the latest data do not disclose revenue share, utilization, or return on capital, so you cannot say the build-out is already paying off. This matters because IT&S organic orders fell 3% in Q1 2026, which means the regional push is happening against a weak organic backdrop. Ingersoll Rand's 2.5% to 4.5% 2026 revenue guidance suggests upside is still developing, not fully captured.

• Question Mark assets need capital, management attention, and time before they can prove market share gains.
• These investments are aimed at growth markets such as life sciences, water, pharma, energy transition, and regional manufacturing.
• The main risk is that Ingersoll Rand may spend before demand, integration, or margin contribution becomes visible.
• The main upside is that a successful build-out can turn a small acquisition or partnership into a stronger platform.

For academic analysis, these Question Mark assets show how Ingersoll Rand is using M&A, partnerships, and capacity expansion to enter markets where demand could grow faster than the core business. The key test is not whether the markets are attractive; it is whether each asset can move from early-stage investment to meaningful scale, measurable orders, and durable margins.

Ingersoll Rand Inc. - BCG Matrix Analysis: Dogs

Ingersoll Rand Inc. has a small set of business pockets that fit the Dog quadrant: low growth, weaker visibility, and limited short-term pricing power. The clearest signs are in long-cycle project work, tariff-sensitive equipment, and organic demand areas where acquisitions are masking softness in the core.

In BCG terms, a Dog is a business unit with low relative market share and low market growth. That matters because these units usually consume management attention and working capital without producing strong reinvestment returns. For Ingersoll Rand Inc., the issue is not company-wide weakness. It is that certain segments are behaving like Dogs even while the broader portfolio still shows healthier areas.

The long-cycle project drag is the clearest Dog-style pocket. In Q1 2026, IT&S posted $1.56B of orders, but organic orders were down 3% and company organic orders were down 1.9%. Middle East geopolitical tensions delayed about $40M of long-cycle project orders in the quarter. That is important because project timing risk weakens revenue visibility and makes near-term forecasting less reliable.

IT&S still produced a 26.7% EBITDA margin, but that was below PST's 30.3% margin. Margin alone does not remove Dog risk here, because the issue is weaker demand quality. When order growth slows and project timing becomes less predictable, the business can still look profitable but remain strategically fragile.

Cash flow confirms the pressure. Q1 2026 free cash flow fell to $163M from $223M in Q1 2025. That decline shows softer cash conversion in the affected project mix. In a Dog quadrant analysis, weak cash conversion matters as much as weak growth because it limits the amount of capital available for higher-return segments.

• Lower order growth reduces forward revenue visibility.
• Delayed project timing makes earnings less predictable.
• Weaker cash conversion increases the burden on portfolio management.

Tariff-exposed equipment also looks Dog-like. Ingersoll Rand Inc. identified dynamic global tariff environments as a material risk on June 9, 2026. Tariff pressure hurts most where products are less differentiated and pricing power is limited. That is a classic Dog problem: the business cannot easily pass through higher costs, so margins can compress faster than revenue can grow.

The company's 2026 revenue growth guidance of 2.5% to 4.5% is modest, especially for the most cyclical pockets of the portfolio. Q1 2026 revenue was $1.85B and net income was $192M. Those numbers are not weak in isolation, but they leave limited room for margin recovery if tariffs intensify. In a Dog segment, even small cost shocks can erase profit gains because the product mix lacks strong pricing leverage.

Organic demand softness reinforces the same view. Q1 2026 organic orders were negative at minus 1.9% even though reported revenue rose 8%. That gap matters because it shows acquisitions are masking weakness in the core. When reported growth relies on deal activity rather than underlying demand, the business unit is closer to a Dog than a Star or Question Mark.

Acquisition dependence is also visible in capital deployment. Ingersoll Rand Inc. completed 16 transactions in 2025 and deployed $525M. That tells you some lower-growth assets may need external growth support. If a unit cannot expand organically and needs repeated deal support just to hold position, it tends to consume strategic capital without building durable market strength.

• Reported revenue growth can hide weak internal demand.
• Deal-driven growth can inflate scale without fixing competitiveness.
• Low organic momentum reduces the case for heavy reinvestment.

The comparison with PST makes the gap clearer. PST posted 1% organic order growth and a 30.3% margin, while IT&S showed minus 3% organic orders and a 26.7% margin. That spread shows which parts of the portfolio have healthier demand and which ones are lagging. In BCG terms, the weaker pockets are not just slower; they are also less efficient at converting orders into profit.

Integration risk adds another layer. Management warned that synergy realization from the high volume of acquisitions could be delayed. That matters most where legacy project work already faces lower organic demand and volatile order timing. If integration takes longer than expected, the business unit can remain stuck in a low-growth, low-visibility state for longer than planned.

Balance sheet strength does not change the quadrant label. Full-year 2025 free cash flow was $1.22B, and the company still had $3.9B of liquidity and 1.7x leverage. That means Ingersoll Rand Inc. is not financially stressed. But Dogs are not defined by solvency; they are defined by weak growth and weak strategic momentum. On that basis, these integration-heavy, tariff-sensitive, and project-delayed areas behave like Dogs rather than growth engines.